Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis

Rheumatology International

Volumn 30, Issue 9, 2010, Pages 1219-1226

  Jiang, Zhongxin ^a,c   Sui, Tao ^b   Wang, Bin ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

Lupus nephritis; MMPs; SLE; TIMPs

Indexed keywords

COMPLEMENT COMPONENT C3; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ALLOANTIBODY; MATRIX METALLOPROTEINASE; PROTEIN; RHO(D) ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN URINE LEVEL; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS; YOUNG ADULT;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; ISOANTIBODIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MATRIX METALLOPROTEINASES; PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; YOUNG ADULT;

EID: 77954425152     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1135-9     Document Type: Article

References (34)

1. JA Mills 1994 Systemic lupus erythematosus N Engl J Med 330 1871 1879 10.1056/NEJM199406303302608 10.1056/NEJM199406303302608 1:STN:280: DyaK2c3lsV2ksQ%3D%3D 8196732
2. BL Kotzin 1996 Systemic lupus erythematosus Cell 85 303 306 10.1016/S0092-8674(00)81108-3 10.1016/S0092-8674(00)81108-3 1:CAS:528: DyaK28XivVyrs78%3D 8616885 (Pubitemid 26160701)
3. VR Kelley RP Wuthrich 1999 Cytokines in the pathogenesis of systemic lupus erythematosus Semin Nephrol 19 57 66 1:STN:280:DyaK1M7jsFOmsA%3D%3D 9952281
4. G Perez de Lema H Maier E Nieto V Vielhauer B Luckow F Mampaso D Schlondorff 2001 Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis J Am Soc Nephrol 12 1369 1382 1:CAS:528:DC%2BD3MXltlSiu7w%3D 11423566
5. HR Chang SF Yang ML Li CC Lin YS Hsieh JD Lian 2006 Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease Clin Chim Acta 366 243 248 10.1016/j.cca.2005.10.007 10.1016/j.cca.2005.10.007 1:CAS:528:DC%2BD28XitVKhtrs%3D 16313894 (Pubitemid 43330990)
6. F Mannello F Luchetti E Falcieri S Papa 2005 Multiple roles of matrix metalloproteinases during apoptosis Apoptosis 10 19 24 10.1007/s10495-005-6058-7 10.1007/s10495-005-6058-7 1:CAS:528:DC%2BD2MXhsVWmsbY%3D 15711919 (Pubitemid 40558112)
7. F Mannello GA Tonti GP Bagnara S Papa 2006 Role and function of matrix metalloproteinases in the differentiation and biological characterization of mesenchymal stem cells Stem Cells 24 475 481 10.1634/stemcells.2005-0333 10.1634/stemcells.2005-0333 1:CAS:528:DC%2BD28XhtFKitbvM 16150919 (Pubitemid 44464750)
8. K Brew D Dinakarpandian H Nagase 2000 Tissue inhibitors of metalloproteinases: evolution, structure and function Biochim Biophys Acta 1477 267 283 1:CAS:528:DC%2BD3cXhsFGktbs%3D 10708863
9. E Lambert E Dasse B Haye E Petitfrere 2004 TIMPs as multifacial proteins Crit Rev Oncol Hematol 49 187 198 10.1016/j.critrevonc.2003.09.008 10.1016/j.critrevonc.2003.09.008 15036259 (Pubitemid 38251351)
10. YH Chang IL Lin GJ Tsay SC Yang TP Yang KT Ho TC Hsu MY Shiau 2008 Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus Clin Biochem 41 955 959 10.1016/j.clinbiochem.2008.04.012 10.1016/j.clinbiochem.2008.04.012 1:CAS:528:DC%2BD1cXoslemtrY%3D 18471998
11. A Faber-Elmann Z Sthoeger A Tcherniack M Dayan E Mozes 2002 Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus Clin Exp Immunol 127 393 398 10.1046/j.1365-2249.2002.01758.x 10.1046/j.1365-2249.2002.01758.x 1:CAS:528:DC%2BD38XislOnsLc%3D 11876767 (Pubitemid 34233949)
12. GS Makowski ML Ramsby 2003 Concentrations of circulating matrix metalloproteinase 9 inversely correlate with autoimmune antibodies to double stranded DNA: implications for monitoring disease activity in systemic lupus erythematosus Mol Pathol 56 244 247 10.1136/mp.56.4.244 10.1136/mp.56.4.244 1:CAS:528:DC%2BD3sXnt12nsLo%3D 12890748 (Pubitemid 36981160)
13. H Ainiala A Hietaharju P Dastidar J Loukkola T Lehtimäki J Peltola M Korpela T Heinonen ST Nikkari 2004 Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities Arthritis Rheum 50 858 865 10.1002/art.20045 10.1002/art.20045 1:CAS:528: DC%2BD2cXjtVCrs7k%3D 15022328 (Pubitemid 38326186)
14. C Matache M Stefanescu C Dragomir S Tanaseanu A Onu A Ofiteru G Szegli 2003 Matrix metalloproteinase-9 and its natural inhibitor TIMP-1 expressed or secreted by peripheral blood mononuclear cells from patients with systemic lupus erythematosus J Autoimmun 20 323 331 10.1016/S0896-8411(03)00037-4 10.1016/S0896-8411(03)00037-4 1:CAS:528:DC%2BD3sXkt1Glu7w%3D 12791318 (Pubitemid 36677524)
15. JF Munoz-Valle M Vazquez-Del Mercado T Garcia-Iglesias G Orozco-Barocio G Bernard-Medina G Martínez-Bonilla BE Bastidas-Ramírez AD Navarro M Bueno E Martínez-López CR Best-Aguilera M Kamachi J Armendáriz-Borunda 2003 T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients Clin Exp Immunol 131 377 384 10.1046/j.1365-2249.2003. 02059.x 10.1046/j.1365-2249.2003.02059.x 1:CAS:528:DC%2BD3sXhs12itL0%3D 12562402 (Pubitemid 36205153)
16. C Mawrin A Brunn C Rocken JM Schroder 2003 Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases Acta Neuropathol 105 365 372 1:CAS:528:DC%2BD3sXhvVyktLY%3D 12624790
17. E Robak A Wierzbowska M Chmiela L Kulczycka A Sysa-Jedrejowska T Robak 2006 Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythematosus Mediators Inflamm 2006 17898 10.1155/MI/2006/17898 10.1155/MI/2006/17898 16864898
18. M Urushihara S Kagami T Kuhara T Tamaki Y Kuroda 2002 Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis Nephrol Dial Transplant 17 1189 1196 10.1093/ndt/17.7.1189 10.1093/ndt/17.7.1189 1:CAS:528:DC%2BD38Xmt1Ojur4%3D 12105240
19. AA Tveita OP Rekvig SN Zykova 2008 Increased glomerular matrix metalloproteinase activity in murine lupus nephritis Kidney Int 74 1150 1158 10.1038/ki.2008.308 10.1038/ki.2008.308 1:CAS:528:DC%2BD1cXht1CmsbfM 18596727
20. S Barille C Akhoundi M Collette MP Mellerin MJ Rapp JL Harousseau R Bataille M Amiot 1997 Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells Blood 90 1649 1655 1:CAS:528:DyaK2sXltlOqsLw%3D 9269785
21. T Kelly M Borset E Abe D Gaddy-Kurten RD Sanderson 2000 Matrix metalloproteinases in multiple myeloma Leuk Lymphoma 37 273 281 1:CAS:528:DC%2BD3MXovVyr 10752979
22. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 10.1002/art.1780400928 10.1002/art.1780400928 1:STN:280: DyaK2svmsVaisw%3D%3D 9324032
23. Liu Y, Zheng M, Yin WH, Zhang B (2004) Relationship of serum levels of HGF and MMP-9 with disease activity of patients with systemic lupus erythematosus. Zhejiang Da Xue Xue Bao Yi Xue Ban 33:340-343, 348
24. M Davies J Martin GJ Thomas DH Lovett 1992 Proteinases and glomerular matrix turnover Kidney Int 41 671 678 10.1038/ki.1992.103 10.1038/ki.1992.103 1:CAS:528:DyaK38XksVGis7s%3D 1573845
25. JT Norman MP Lewis 1996 Matrix metalloproteinases (MMPs) in renal fibrosis Kidney Int Suppl 54 S61 S63 1:CAS:528:DyaK28XkslSlsbs%3D 8731197
26. K Akiyama K Shikata H Sugimoto 1997 Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis Res Commun Mol Pathol Pharmacol 95 115 118 1:CAS:528:DyaK2sXisFGnu74%3D 9090749
27. T Okamoto 2006 NF-kappaB and rheumatic diseases Endocr Metab Immune Disord Drug Targets 6 359 372 1:CAS:528:DC%2BD28XhtlSjurnJ 17214582
28. DE Gomez DF Alonso H Yoshiji UP Thorgeirsson 1997 Tissue inhibitors of metalloproteinases: structure, regulation and biological functions Eur J Cell Biol 74 111 122 1:CAS:528:DyaK2sXmslSqsLg%3D 9352216
29. L Guedez WG Stetler-Stevenson L Wolff J Wang P Fukushima A Mansoor M Stetler-Stevenson 1998 In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1 J Clin Invest 102 2002 2010 10.1172/JCI2881 10.1172/JCI2881 1:CAS:528:DyaK1cXnvVertbc%3D 9835626
30. TY Chen YS Hsieh CC Yang CP Wang SF Yang YW Cheng HL Chiou 2005 Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease Clin Biochem 38 632 638 10.1016/j.clinbiochem. 2005.03.005 10.1016/j.clinbiochem.2005.03.005 1:CAS:528:DC%2BD2MXmtFGisr8%3D 16009142 (Pubitemid 40961633)
31. WH Kuo FP Chou SC Lu SC Chu YS Hsieh 2000 Significant differences in serum activities of matrix metalloproteinase-2 and-9 between HCV and HBV-infected patients and carriers Clin Chim Acta 294 157 168 10.1016/S0009-8981(00)00182-0 10.1016/S0009-8981(00)00182-0 1:CAS:528: DC%2BD3cXhvV2ms7Y%3D 10727681 (Pubitemid 30155815)
32. SF Yang SC Chu IC Chiang WF Kuo HL Chiou FP Chou WH Kuo YS Hsieh 2005 Excessive matrix metalloproteinase-9 in the plasma of community-acquired pneumonia Clin Chim Acta 352 209 215 10.1016/j.cccn.2004.09.025 10.1016/j.cccn.2004.09.025 1:CAS:528:DC%2BD2MXkvFalsw%3D%3D 15653116 (Pubitemid 40093873)
33. E Rodrigo M Lopez-Hoyos R Escallada G Fernández-Fresnedo JC Ruiz C Piñera JG Cotorruelo JA Zubimendi AL de Francisco M Arias 2000 Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy Nephrol Dial Transplant 15 2041 2045 10.1093/ndt/15.12.2041 10.1093/ndt/15.12.2041 1:CAS:528:DC%2BD3cXptVeitLo%3D 11096152
34. FP Chou SC Chu MC Cheng SF Yang WN Cheung HL Chiou YS Hsieh 2002 Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors Clin Biochem 35 383 388 10.1016/S0009-9120(02)00331-4 10.1016/S0009-9120(02) 00331-4 1:CAS:528:DC%2BD38Xos1erurw%3D 12270768 (Pubitemid 35247947)